Henry Schein (HSIC) reported $3.17 billion in revenue for the quarter ended September 2024, representing a year-over-year increase of 0.4%. EPS of $1.22 for the same period compares to $1.32 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $3.24 billion, representing a surprise of -2.05%. The company delivered an EPS surprise of +5.17%, with the consensus EPS estimate being $1.16.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- an ...

Henry Schein, Inc. (HSIC) registered adjusted earnings per share (EPS) of $1.22 in the third quarter of 2024, down 7.6% from the year-ago figure. However, the metric exceeded the Zacks Consensus Estimate by 5.2%.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.Following the earnings announcement, HSIC stock rose 0.03% at pre-market trading today.HSIC’s Q3 Revenues in DetailHenry Schein reported net sales of $3.17 billion, up a marginal 0.4% year over year. The metric lagged the Zacks C ...

Henry Schein (HSIC) came out with quarterly earnings of $1.22 per share, beating the Zacks Consensus Estimate of $1.16 per share. This compares to earnings of $1.32 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 5.17%. A quarter ago, it was expected that this health care products maker would post earnings of $1.22 per share when it actually produced earnings of $1.23, delivering a surprise of 0.82%.Over the last four quarters ...

PRESS RELEASE FOR IMMEDIATE RELEASE HENRY SCHEIN REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND INCREASES 2024 FINANCIAL GUIDANCE ● Third-quarter 2024 GAAP diluted EPS of $0.78 and non-GAAP dilutedEPS of $1.22 ● Operating cash flow of $151 million for the third quarter of 2024; year-to-date operating cash flow of $644 million, up $112 million compared with year-to-date 2023 ● Increases 2024 full-year non-GAAP EPS guidance to $4.74 to $4.82 from $4.70 to $4.82 MELVILLE, N.Y., November 5, 2024 – Henry Schei ...

Core Viewpoint - The market anticipates a year-over-year decline in earnings for Henry Schein (HSIC) despite an increase in revenues when it reports its quarterly results for September 2024, with actual results being crucial for stock price movement [1][2]. Earnings Expectations - Henry Schein is expected to report quarterly earnings of $1.16 per share, reflecting a year-over-year decrease of 12.1%, while revenues are projected to reach $3.24 billion, representing a 2.5% increase from the previous year [3]. Estimate Revisions - The consensus EPS estimate has been revised 0.27% higher in the last 30 days, indicating a slight bullish sentiment among analysts regarding the company's earnings prospects [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model shows that the Most Accurate Estimate for Henry Schein is higher than the Zacks Consensus Estimate, resulting in a positive Earnings ESP of +0.09%, suggesting a likelihood of beating the consensus EPS estimate [10]. Historical Performance - In the last reported quarter, Henry Schein exceeded the expected earnings of $1.22 per share by posting $1.23, achieving a surprise of +0.82%. Over the last four quarters, the company has beaten consensus EPS estimates twice [11][12]. Investment Considerations - While a potential earnings beat may increase stock price, other factors can also influence stock movement, making it essential for investors to consider the broader context beyond just earnings results [13][15].

Core Viewpoint - Henry Schein, Inc. is set to release its third-quarter 2024 results on November 5, with expectations of a revenue increase but a decline in earnings per share (EPS) compared to the previous year [1][2]. Group 1: Earnings and Revenue Estimates - The Zacks Consensus Estimate for revenues is $3.24 billion, reflecting a 2.5% increase from the same quarter last year [2]. - The Zacks Consensus Estimate for EPS is $1.17, indicating an 11.4% year-over-year decline [2]. - In the last reported quarter, the company achieved adjusted EPS of $1.23, surpassing the Zacks Consensus Estimate by 0.8% [1]. Group 2: Estimate Revision and Trends - Estimates for Henry Schein's third-quarter earnings have remained unchanged at $1.17 per share over the past 30 days [3]. - The company has had mixed performance in the past four quarters, with one meeting estimates, two surpassing, and one missing, resulting in an average negative surprise of 1.56% [1]. Group 3: Factors Influencing Performance - The recovery from last year's cybersecurity incident is expected to continue, particularly in the dental and medical distribution sectors [4]. - Sales trends in dental distribution are anticipated to improve as the company focuses on regaining episodic customers [4]. - The THRIVE Signature program is likely to contribute to overall sales growth through increased memberships [4]. Group 4: Business Developments - Sales of dental implant products in Europe are expected to grow due to competitive offerings, while North America is anticipated to see sales growth from a new product line [5]. - Recent acquisitions, such as abc dental AG in Switzerland, are expected to enhance the company's service offerings [5]. - The opening of an 811K-square-foot distribution center in Fort Worth, TX, is projected to positively impact revenues [5]. Group 5: Technology and Services - The technology segment, particularly Henry Schein One, is expected to drive growth, with a customer base for cloud-based solutions showing over 25% year-over-year growth [6]. - Collaborations between Henry Schein One and distribution businesses are anticipated to support growth, with new software integrations enhancing operational efficiency [7]. - Despite some challenges, the Home Solutions business is expected to perform well [7].

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Henry Schein (HSIC) . This company, which is in the Zacks Medical - Dental Supplies industry, shows potential for another earnings beat. This health care products maker has an established record of topping earnings estimates, especially when looking at the previous two reports. The company boasts an average surprise for the pa ...

Henry Schein's (HSIC) dental software business, Henry Schein One, has introduced two new tools — Eligibility Essentials and Eligibility Pro — to simplify the insurance eligibility process for dental practices. Currently available for Dentrix and Dentrix Ascend cloud-based practice management solutions, the new tools are designed to help foster trust between dental practices and patients by reducing insurance-related surprises. Henry Schein One is the largest component in the company's Technology and value-a ...

A month has gone by since the last earnings report for Henry Schein (HSIC) . Shares have added about 5.6% in that time frame, underperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release, or is Henry Schein due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts. Henry Schein (HSIC) , has gained 8.6% over the ...

Henry Schein (HSIC) reported $3.14 billion in revenue for the quarter ended June 2024, representing a yearover-year increase of 1.2%. EPS of $1.23 for the same period compares to $1.31 a year ago. The reported revenue represents a surprise of -4.33% over the Zacks Consensus Estimate of $3.28 billion. With the consensus EPS estimate being $1.22, the EPS surprise was +0.82%. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street ...